Pahilangco, Maylyn S.
HRN: 26-16-63 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2024
CEFUROXIME 1.5GM (VIAL)
11/03/2024
11/03/2024
IV
1.5
PTOR
Malpresentation
Waiting Final Action
11/03/2024
CEFUROXIME 500MG (TAB)
11/03/2024
11/09/2024
PO
BID
BID
CS
Waiting Final Action